The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.
- Citation:
- Breast Cancer Res Treat vol 203 (3) 497-509
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 13
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, UG1CA233180, UG1CA233196, UG1CA233329, UG1CA232760; U10CA180863
- Corr. Author:
- Authors:
- Diogo Martins-Branco Marie Kassapian Véronique Debien Rafael Caparica Daniel Eiger Urania Dafni Charitini Andriakopoulou Sarra El-Abed Susan L Ellard Miguel Izquierdo Malou Vicente Saranya Chumsri Martine Piccart-Gebhart Alvaro Moreno-Aspitia Ann Søegaard Knop Janine Lombard Evandro de Azambuja
- Networks:
- Study
- NCCTG-N063D
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: